The Self-Evaluation of Communication Experiences for Laryngeal Cancer (SECEL) remains the most extensively validated and reliable tool, with strong evidence supporting its clinical utility.
It has been validated in patients with laryngeal cancer (LC) across different countries and treatment modalities.
However, it has not yet translated, adapted, and validated into the Arabic version, highlighting a gap in accessible assessment tools for Arabic-speaking patients.
